Lukas Biomedical Inc. (6814.TWO)
TWD 30.05
(0.0%)
TWD 30.05
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 50.75 Million TWD | 30.35% |
| 2022 | 72.16 Million TWD | -53.94% |
| 2021 | 156.66 Million TWD | -9.58% |
| 2020 | 173.25 Million TWD | -5.82% |
| 2019 | 183.96 Million TWD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -45.42 Million TWD | -189.49% |
| 2024 Q2 | -45.42 Million TWD | 80.87% |
| 2023 Q4 | 50.75 Million TWD | 0.0% |
| 2023 Q3 | 50.75 Million TWD | -39.98% |
| 2023 Q2 | 84.55 Million TWD | 146.3% |
| 2023 Q1 | 34.33 Million TWD | -52.42% |
| 2022 FY | 72.16 Million TWD | -53.94% |
| 2022 Q4 | 72.16 Million TWD | 0.0% |
| 2021 FY | 156.66 Million TWD | -9.58% |
| 2020 FY | 173.25 Million TWD | -5.82% |
| 2019 FY | 183.96 Million TWD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Bio Preventive Medicine Corp. | 31.8 Million TWD | -59.562% |
| Genomics BioSci & Tech. Co.,Ltd. | 30.57 Million TWD | -65.985% |
| Advagene Biopharma Co., Ltd. | -64.32 Million TWD | 178.909% |
| Taiwan Bio Therapeutics Co., Ltd | 20.48 Million TWD | -147.791% |
| NaviFUS Corp. | -123.12 Million TWD | 141.221% |
| G&E Herbal Biotechnology Co., Ltd. | -134.25 Million TWD | 137.806% |
| TaiRx, Inc. | -147.86 Million TWD | 134.324% |
| Sinew Pharma Inc. | -160.34 Million TWD | 131.654% |
| Lin BioScience, Inc. | -3.21 Billion TWD | 101.577% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -57.65 Million TWD | 188.028% |
| Lumosa Therapeutics Co., Ltd. | -412.63 Million TWD | 112.3% |
| Anti-Microbial Savior BioteQ Co., Ltd | -77.04 Million TWD | 165.878% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | -264.16 Million TWD | 119.213% |
| AP Biosciences Inc | -196.52 Million TWD | 125.826% |
| Sunmax Biotechnology Co., Ltd. | -680.6 Million TWD | 107.457% |
| RBC Bioscience Corporation | 422.18 Million TWD | 87.978% |
| Syngen Biotech Co.,Ltd. | 314.87 Million TWD | 83.881% |
| EirGenix Inc. | -4.58 Billion TWD | 101.106% |
| Enimmune corporation | -314.15 Million TWD | 116.156% |
| BRIM Biotechnology, Inc. | -944.4 Million TWD | 105.374% |
| 3D Global Biotech Inc. | -11.43 Million TWD | 543.779% |
| TaiMed Biologics Inc. | 499.84 Million TWD | 89.846% |
| Mycenax Biotech Inc. | 207 Million TWD | 75.482% |
| TCI GENE Inc. | -689.25 Million TWD | 107.364% |
| SynCore Biotechnology Co.,Ltd | -262.58 Million TWD | 119.329% |
| Oneness Biotech Co., Ltd. | -414.87 Million TWD | 112.234% |
| Eusol Biotech Co.,Ltd. | -209.33 Million TWD | 124.245% |
| Feng Chi Biotech Corp. | -19.81 Million TWD | 356.17% |
| NeoCore Technology Co., Ltd. | -196.39 Million TWD | 125.843% |
| TWi Biotechnology, Inc. | -143.86 Million TWD | 135.28% |
| Neith Corporation | -150.31 Million TWD | 133.767% |
| Sunny Pharmtech Inc. | 120.87 Million TWD | 58.009% |
| VBI | -25.31 Million TWD | 300.486% |
| Ever Supreme Bio Technology Co., Ltd | -330.54 Million TWD | 115.355% |
| GeneReach Biotechnology Corp. | 40.26 Million TWD | -26.049% |
| Shine-On BioMedical Co.,Ltd. | -101.48 Million TWD | 150.012% |
| CHO Pharma, Inc. | -203.79 Million TWD | 124.905% |
| Andros Pharmaceuticals Co.,Ltd | -241.89 Million TWD | 120.982% |
| MegaPro Biomedical Co., Ltd | -118.93 Million TWD | 142.673% |
| Visgeneer Inc. | 31.28 Million TWD | -62.239% |
| Greenyn Biotechnology Co., Ltd | -337.37 Million TWD | 115.044% |
| BioLASCO Taiwan Co., Ltd. | -84.76 Million TWD | 159.879% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 74.05 Million TWD | 31.459% |
| Sagittarius Life Science Corp | -120.57 Million TWD | 142.096% |
| BioGend Therapeutics Co., Ltd. | -317.41 Million TWD | 115.99% |
| GlycoNex Incorporation | -148.56 Million TWD | 134.163% |
| Medigen Biotechnology Corp. | 688.73 Million TWD | 92.631% |
| Pharmosa Biopharm Inc. | -829.69 Million TWD | 106.117% |
| PharmaEngine, Inc. | -860.8 Million TWD | 105.896% |
| Intech Biopharm Corporation | 1.35 Billion TWD | 96.261% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 137.99 Million TWD | 63.22% |
| BiOptic Inc. | 12.59 Million TWD | -303.073% |
| TaiGen Biopharmaceuticals Holdings Limited | -299.96 Million TWD | 116.92% |
| Senhwa Biosciences, Inc. | -1.3 Billion TWD | 103.877% |
| NatureWise Biotech & Medicals Corporation | -101.87 Million TWD | 149.823% |
| OBI Pharma, Inc. | -398.22 Million TWD | 112.745% |
| Savior Lifetec Corporation | -812.54 Million TWD | 106.246% |
| Great Novel Therapeutics Biotech & Medicals | -165.17 Million TWD | 130.728% |
| Level Biotechnology Inc. | -453.9 Million TWD | 111.182% |
| Medigen Vaccine Biologics Corporation | 621.53 Million TWD | 91.834% |
| Meribank Biotech Co., Ltd | -365.41 Million TWD | 113.89% |
| Acepodia, Inc. | -6.02 Billion TWD | 100.843% |
| Caliway Biopharmaceuticals Co., Ltd. | -3.4 Billion TWD | 101.492% |